Medicare Enrolled
Dr. Robert Hong, M.D.
Urology Physician · Lancaster, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hong from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hong?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hong
Dr. Robert Hong is an urology physician in Lancaster, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hong performed 8,770 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Hong received a total of $4,583 from 45 pharmaceutical and/or device companies across 236 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hong is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 4% volume in PA
$4,583 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗8,770
Medicare services
Top 4% in PA for urology physician
Not available
Unique patients (not deduplicated)
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,500 | $0 | $3 |
| BCG treatment for bladder cancer | 1,845 | $2 | $4 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
755 | $2 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
666 | $88 | $210 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
479 | $61 | $139 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
258 | $76 | $316 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
239 | $7 | $41 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
166 | $3 | $20 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
118 | $116 | $323 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
96 | $58 | $585 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
95 | $38 | $84 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
65 | $42 | $249 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
44 | $65 | $553 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
42 | $62 | $201 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
39 | $194 | $800 |
| PSA test (prostate cancer screening) | 38 | $18 | $120 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
34 | $8 | $15 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
31 | $75 | $210 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
24 | $19 | $260 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
23 | $138 | $600 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
22 | $100 | $281 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
19 | $55 | $476 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
19 | $275 | $594 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
19 | $7 | $209 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
18 | $24 | $559 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
17 | $145 | $419 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
17 | $103 | $327 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
16 | $136 | $284 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
15 | $98 | $907 |
| Ultrasound of scrotum An imaging test that uses sound waves to create pictures of the scrotum and its contents. It helps evaluate the testicles and surrounding structures. |
15 | $67 | $266 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
14 | $25 | $115 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
11 | $167 | $904 |
| Complete pelvic ultrasound An imaging test using sound waves to create pictures of the organs and structures within the pelvis. |
11 | $80 | $297 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.2% high complexity
47.1% medium
52.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,583
Total received (2018-2024)
Avg $655/year across 7 years
Top 30% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
236
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$602
2023
$1,068
2022
$865
2021
$712
2020
$205
2019
$636
2018
$494
Payments by company (2024)
ABBVIE INC.
$125
Teleflex LLC
$99
Sumitomo Pharma America, Inc.
$81
UROGEN PHARMA, INC.
$69
PROGENICS PHARMACEUTICALS, INC.
$54
Bayer Healthcare Pharmaceuticals Inc.
$31
180 Medical, Inc.
$29
AstraZeneca Pharmaceuticals LP
$23
Janssen Biotech, Inc.
$21
COLOPLAST CORP
$21
Myriad Genetic Laboratories, Inc.
$20
Merck Sharp & Dohme LLC
$15
Astellas Pharma US Inc
$14
Top 3 companies account for 50.7% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$576
Astellas Pharma US Inc
$522
Janssen Biotech, Inc.
$465
AstraZeneca Pharmaceuticals LP
$464
Sumitomo Pharma America, Inc.
$221
Dendreon Pharmaceuticals LLC
$211
ABBVIE INC.
$154
Merck Sharp & Dohme LLC
$137
Boston Scientific Corporation
$124
Amgen Inc.
$113
UroGen Pharma, Inc.
$110
UROGEN PHARMA, INC.
$104
Janssen Products, LP
$100
Teleflex LLC
$99
UROVANT SCIENCES INC
$97
NeoTract Inc.
$91
AbbVie, Inc.
$91
Merck Sharp & Dohme Corporation
$90
180 Medical, Inc.
$73
Bayer HealthCare Pharmaceuticals Inc.
$66
Bayer Healthcare Pharmaceuticals Inc.
$65
COLOPLAST CORP
$54
PROGENICS PHARMACEUTICALS, INC.
$54
TOLMAR Pharmaceuticals, Inc.
$53
Coloplast Corp
$38
AbbVie Inc.
$38
C. R. Bard, Inc. & Subsidiaries
$36
ConvaTec Inc.
$32
Axonics, Inc.
$28
Myovant Sciences Inc.
$28
Travere Therapeutics, Inc.
$22
Foundation Medicine, Inc.
$22
Myriad Genetic Laboratories, Inc.
$20
Allergan, Inc.
$20
Baxter Healthcare
$20
Sun Pharmaceutical Industries Inc.
$19
ABC Home Medical Supply, Inc.
$18
ACCORD HEALTHCARE, INC.
$17
Avadel Specialty Pharmaceuticals, LLC
$16
BAXTER HEALTHCARE
$15
E.R. Squibb & Sons, L.L.C.
$14
Olympus America Inc.
$13
Ferring Pharmaceuticals Inc.
$11
EMD Serono, Inc.
$11
Ethicon US, LLC
$11
Top 3 companies account for 34.1% of all-time payments
Associated products mentioned in payments ›
Axonics · BARDEX I.C. TIEMANN MODEL COUDE TIP FOLEY CATHETER · BOTOX · Balversa · Bard Urinary Drainage Bag · Bavencio · CAMCEVI · ECHELON FLEX Stapler · ELIGARD · ERLEADA · Erleada · Flexiva · GEMTESA · GENTLECATH · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · OPDIVO · ORGOVYX · PROLARIS · PROVENGE · PYLARIFY · Prolia · SpeediCath · TISSEEL · Thiola · UROLIFT · UroLift · Veozah · X-FORCE · XGEVA · XTANDI · Xofigo · Xtandi · YONSA · ZYTIGA · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
48
County median income
$83,703
Nearest hospital to ZIP centroid (approximate)
PENN STATE HEALTH LANCASTER MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hong is a mixed practice specialist, with above-average Medicare volume (top 4% in PA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hong experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Hong performed 3,500 contrast dye for imaging (iodine-based) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Hong receive payments from pharmaceutical companies?
Yes. Dr. Hong received a total of $4,583 from 45 companies across 236 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hong's costs compare to other urology physicians in Lancaster?
Dr. Hong's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hong) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Lancaster
Browse urology physicians in Lancaster ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in PA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in PA
Which PA urology physicians receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology